Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors.
about
PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα InhibitionTargeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival.A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.SGK1: The Dark Side of PI3K Signaling.Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinaseStachydrine hydrochloride inhibits proliferation and induces apoptosis of breast cancer cells via inhibition of Akt and ERK pathwaysExpression of serum- and glucocorticoid-regulated kinase 1 and its association with clinicopathological factors and the survival of patients with adenocarcinoma of the esophagogastric junction.Estradiol Suppresses TLR4-triggered Apoptosis of Decidual Stromal Cells and Drives an Anti-inflammatory TH2 Shift by Activating SGK1.mTORC2 regulates renal tubule sodium uptake by promoting ENaC activity.Targeting serum glucocorticoid-regulated kinase-1 in squamous cell carcinoma of the head and neck: a novel modality of local controlCombinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades.The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration.The tumor suppressor PTEN and the PDK1 kinase regulate formation of the columnar neural epitheliumINPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapyHsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast CancerDeletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24.SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells.Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletionThe hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growthThe histone demethylase JMJD2A/KDM4A links ribosomal RNA transcription to nutrients and growth factors availability.Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system.Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibitionGenomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation.AKT-independent PI3-K signaling in cancer - emerging role for SGK3.Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1.Targeting PI3K/Akt/mTOR Signaling in Cancer.Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinasesOncogenic MNK signalling regulates the metastasis suppressor NDRG1Ras-ling with new therapeutic targets for metastasis.PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets.mTORC1 and mTORC2 in cancer and the tumor microenvironment.The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase.PI3K signaling in cancer: beyond AKT.AKT/PKB Signaling: Navigating the Network.Oncogenic Ras differentially regulates metabolism and anoikis in extracellular matrix-detached cells.Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas.The emerging role of serum/glucocorticoid-regulated kinases in cancer.
P2860
Q28118735-783C7AE0-3052-47B8-97E7-645FFAB6BBF3Q28550300-B4E5DD3F-5AF3-4D4F-914C-10DEFF845841Q30363869-5AE71A1F-697B-4A96-A95C-94DE33CF9DBAQ30396975-9DC61C70-C215-45CE-A8B1-1BC60F4DEB09Q30399129-E46DE64D-A492-418F-A721-4B20B7565826Q30427499-D8015914-332E-4E2D-90FF-258D62AEA1FAQ33623156-7EBC105D-8C28-407B-8649-388ECED77C93Q33685686-CF85E91D-FB2F-4061-88FB-65772562DB0CQ33703276-258094C2-A7AC-4814-A199-8936C107E207Q35242354-3FD2B813-DDD6-45A9-8C39-FA23D04E7CB9Q35499408-439D94F9-A175-40C2-AE69-753B9E35A802Q35690166-82766E03-1C7F-4460-ADB8-E97DF04B7605Q35793635-B693AFDF-B784-4B47-BB6E-3B9C39708F69Q36539705-C717BE07-2AB2-4899-9E22-1672469BA446Q36545503-6101332E-3340-40BD-9E73-4B5026183F5AQ36545796-593679C8-807A-42F0-A25C-2F8A7E481101Q36679783-5D54C20C-CDAA-4751-BA78-EFC48CFDDE41Q36811339-68ADEA2D-EFB4-46D7-A5C0-AC7B3922AA45Q37085905-D700144B-BAC0-44BC-AECE-145E197F5094Q37142812-DE9E5DAE-32A2-458A-BBD8-3D5A7D0801A0Q37223549-FDCA2437-CBE9-4607-9E45-84C9CC894031Q37505139-60A906F1-7375-4D2B-B952-F611FAE3EB33Q37677594-17AAD500-D8D3-4E08-8778-352A7CA5332CQ37716027-F648B7CC-CCFA-4B1F-8C46-E6DDB0312D51Q37718224-BF3903B6-8CBB-4BF1-B1B8-96CA1449479EQ37727820-DABCFCCF-DC28-44E0-B4B4-55A211B584F5Q38134714-99A1106C-25F8-45AB-A106-264A9535AF0BQ38177872-E8C9580E-749F-4096-9D15-C873ECC85338Q38208314-53509614-DEFB-4CE1-B984-6DFE83B294F5Q38552068-B63F0EA4-B34C-4B28-9DCD-769F748FBBDCQ38763490-F79AC693-24A1-4F27-8C15-964361C4E040Q38805139-329ED3AA-E611-4E94-84F5-19B70BBF2D3FQ38906407-F25425E7-80C7-44C4-836E-59A88D40C16BQ38982579-236CC68A-6D40-40CA-98C3-AB70D9324465Q39021890-BF1216DE-F711-4DEB-BB78-0091074825DDQ39200710-2EE27FF5-4592-4D66-B79B-F2BA8CCFB54BQ39255027-0AF91662-CAB4-4CBA-8934-4A8F88F5C582Q39968484-075802B7-3DAE-4A7A-99C5-0B4387B9E664Q40058161-1E53E6C4-32D6-4739-A9D6-4DDAAE7DE2D7Q41728566-5D632914-9F18-4829-99CA-7FB53DEED990
P2860
Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors.
@en
type
label
Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors.
@en
prefLabel
Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors.
@en
P2093
Barry R Davies
Darren Cross
Eeva M Sommer
Hannah Dry
Sylvie Guichard
P2860
P304
P356
10.1042/BJ20130342
P407
P577
2013-06-01T00:00:00Z